Tetrahydropyridopyrimidine compound or salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9889136
APP PUB NO 20160310496A1
SERIAL NO

15203059

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for inhibiting androgen activity, including administering an effective amount of a tetrahydropyridopyrimidine compound of formula (I) or a pharmaceutically acceptable salt thereof to a subject in need thereof, and a method for treating tumor, including administering an effective amount of a tetrahydropyridopyrimidine compound of formula (I) or a pharmaceutically acceptable salt thereof to a subject in need thereof

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TAIHO PHARMACEUTICAL CO., LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aoki, Shinichi Honjo, JP 49 283
Asai, Masanori Tsukuba, JP 15 30
Asai, Takahiro Tsukuba, JP 291 3323
Dohi, Suguru Bunkyo-ku, JP 4 10
Minamiguchi, Kazuhisa Moriya, JP 4 10
Okajima, Shigeo Tsukuba, JP 11 71
Yamanaka, Hiroyoshi Moriya, JP 9 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00